Remicade Biosimilar Market Report

Global and Region Remicade Biosimilar Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：162
  • REPORT CODE：GMM1001925
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 

    The report details the trend, potential and market size of Remicade Biosimilar market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Remicade Biosimilarmarket, defines the market attractiveness level of Remicade Biosimilar market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Remicade Biosimilar industry, describes the types of Remicade Biosimilar market, the applications of major players and the market size, and deeply analyzes the current situation of the global Remicade Biosimilar market and the development prospects and opportunities of Remicade Biosimilar industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Remicade Biosimilar market in Chapter 13.

    By Player:

    • Hospira

    • Novartis (Sandoz)

    • Genentech (Roche Group)

    • Celltrion

    • LG Life Sciences

    • Merck Serono (Merck Group)

    • Synthon Pharmaceuticals

    • Biocon

    By Type:

    • 100mg/10ml

    • 500mg/50ml

    By End-User:

    • Blood Disorders

    • Oncology Diseases

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Remicade Biosimilar Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Remicade Biosimilar Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Remicade Biosimilar Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Remicade Biosimilar Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Remicade Biosimilar Market Analysis and Outlook to 2022

    • 7.1 Global Remicade Biosimilar Consumption (2017-2022)

    • 7.2 United States Remicade Biosimilar Consumption (2017-2022)

    • 7.3 Europe Remicade Biosimilar Consumption (2017-2022)

    • 7.4 China Remicade Biosimilar Consumption (2017-2022)

    • 7.5 Japan Remicade Biosimilar Consumption (2017-2022)

    • 7.6 India Remicade Biosimilar Consumption (2017-2022)

    • 7.7 South Korea Remicade Biosimilar Consumption (2017-2022)

    8 Region and Country-wise Remicade Biosimilar Market Analysis and Outlook to 2028

    • 8.1 Global Remicade Biosimilar Consumption Forecast (2022-2028)

    • 8.2 United States Remicade Biosimilar Consumption Forecast (2022-2028)

    • 8.3 Europe Remicade Biosimilar Consumption Forecast (2022-2028)

    • 8.4 China Remicade Biosimilar Consumption Forecast (2022-2028)

    • 8.5 Japan Remicade Biosimilar Consumption Forecast (2022-2028)

    • 8.6 India Remicade Biosimilar Consumption Forecast (2022-2028)

    • 8.7 South Korea Remicade Biosimilar Consumption Forecast (2022-2028)

    9 Global Remicade Biosimilar Market Outlook by Types and Applications to 2022

    • 9.1 Global Remicade Biosimilar Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 100mg/10ml Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 500mg/50ml Consumption and Growth Rate (2017-2022)

    • 9.2 Global Remicade Biosimilar Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Diseases Consumption and Growth Rate (2017-2022)

    10 Global Remicade Biosimilar Market Outlook by Types and Applications to 2028

    • 10.1 Global Remicade Biosimilar Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 100mg/10ml Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 500mg/50ml Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Remicade Biosimilar Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

    11 Global Remicade Biosimilar Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Remicade Biosimilar Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Remicade Biosimilar Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Remicade Biosimilar Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Remicade Biosimilar Market Competitive Analysis

    • 14.1 Hospira

      • 14.1.1 Hospira Company Details

      • 14.1.2 Hospira Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Hospira Remicade Biosimilar Product and Service

    • 14.2 Novartis (Sandoz)

      • 14.2.1 Novartis (Sandoz) Company Details

      • 14.2.2 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis (Sandoz) Remicade Biosimilar Product and Service

    • 14.3 Genentech (Roche Group)

      • 14.3.1 Genentech (Roche Group) Company Details

      • 14.3.2 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Genentech (Roche Group) Remicade Biosimilar Product and Service

    • 14.4 Celltrion

      • 14.4.1 Celltrion Company Details

      • 14.4.2 Celltrion Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Celltrion Remicade Biosimilar Product and Service

    • 14.5 LG Life Sciences

      • 14.5.1 LG Life Sciences Company Details

      • 14.5.2 LG Life Sciences Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 LG Life Sciences Remicade Biosimilar Product and Service

    • 14.6 Merck Serono (Merck Group)

      • 14.6.1 Merck Serono (Merck Group) Company Details

      • 14.6.2 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Serono (Merck Group) Remicade Biosimilar Product and Service

    • 14.7 Synthon Pharmaceuticals

      • 14.7.1 Synthon Pharmaceuticals Company Details

      • 14.7.2 Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Synthon Pharmaceuticals Remicade Biosimilar Product and Service

    • 14.8 Biocon

      • 14.8.1 Biocon Company Details

      • 14.8.2 Biocon Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biocon Remicade Biosimilar Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Remicade Biosimilar

    • Figure Remicade Biosimilar Picture

    • Table Global Remicade Biosimilar Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Remicade Biosimilar Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Remicade Biosimilar Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Remicade Biosimilar Consumption by Country (2017-2022)

    • Figure United States Remicade Biosimilar Consumption and Growth Rate (2017-2022)

    • Table Europe Remicade Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure China Remicade Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Japan Remicade Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure India Remicade Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure South Korea Remicade Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Global Remicade Biosimilar Consumption Forecast by Country (2022-2028)

    • Figure United States Remicade Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Remicade Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Remicade Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Remicade Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Remicade Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Remicade Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 100mg/10ml Consumption and Growth Rate (2017-2022)

    • Figure Global 500mg/50ml Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global 100mg/10ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 500mg/50ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Remicade Biosimilar Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Remicade Biosimilar Export by Region (Top 5 Countries) (2017-2028)

    • Table Hospira (Foundation Year, Company Profile and etc.)

    • Table Hospira Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Remicade Biosimilar Product and Service

    • Table Novartis (Sandoz) (Foundation Year, Company Profile and etc.)

    • Table Novartis (Sandoz) Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis (Sandoz) Remicade Biosimilar Product and Service

    • Table Genentech (Roche Group) (Foundation Year, Company Profile and etc.)

    • Table Genentech (Roche Group) Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech (Roche Group) Remicade Biosimilar Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Remicade Biosimilar Product and Service

    • Table LG Life Sciences (Foundation Year, Company Profile and etc.)

    • Table LG Life Sciences Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Remicade Biosimilar Product and Service

    • Table Merck Serono (Merck Group) (Foundation Year, Company Profile and etc.)

    • Table Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Serono (Merck Group) Remicade Biosimilar Product and Service

    • Table Synthon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthon Pharmaceuticals Remicade Biosimilar Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Remicade Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Remicade Biosimilar Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US